These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19621671)

  • 1. Statin use and risk of gastroduodenal ulcer and reflux esophagitis.
    Fujii T; Nakabayashi T; Hashimoto S; Kuwano H
    Hepatogastroenterology; 2009; 56(91-92):641-4. PubMed ID: 19621671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between serum triglycerides and gastro-duodenal ulcer associated with low-dose aspirin.
    Fujii T; Nakabayashi T; Hashimoto S; Kuwano H
    Hepatogastroenterology; 2009; 56(93):1241-4. PubMed ID: 19760979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
    Rea TD; Breitner JC; Psaty BM; Fitzpatrick AL; Lopez OL; Newman AB; Hazzard WR; Zandi PP; Burke GL; Lyketsos CG; Bernick C; Kuller LH
    Arch Neurol; 2005 Jul; 62(7):1047-51. PubMed ID: 16009757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
    McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE
    J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for erosive reflux esophagitis: a case-control study.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Am J Gastroenterol; 2001 Jan; 96(1):41-6. PubMed ID: 11197285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering drugs and the risk of depression and suicidal behavior.
    Yang CC; Jick SS; Jick H
    Arch Intern Med; 2003 Sep; 163(16):1926-32. PubMed ID: 12963565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
    Douketis JD; Melo M; Bell CM; Mamdani MM
    Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of statin hepatotoxicity in patients with hepatitis C.
    Khorashadi S; Hasson NK; Cheung RC
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):902-7; quiz 806. PubMed ID: 16697272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study.
    Munk EM; Drewes AM; Gorst-Rasmussen A; Gregersen H; Funch-Jensen P; Nørgård B
    Aliment Pharmacol Ther; 2007 May; 25(10):1203-10. PubMed ID: 17451566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding reflux esophagitis: a prospective 1-year study in a university hospital.
    Costa ND; Cadiot G; Merle C; Jolly D; Bouche O; Thiéfin G; Zeitoun P
    Am J Gastroenterol; 2001 Jan; 96(1):47-51. PubMed ID: 11197286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statins on the occurrence of peptic ulcer.
    Feng A; Chuang E; Wu SH; Wang JC; Chang SN; Lin CL; Kao CH
    Eur J Intern Med; 2015 Nov; 26(9):731-5. PubMed ID: 26226858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic statin therapy and the risk of colorectal cancer.
    Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
    Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and risk of lymphoid neoplasms: results from the European Case-Control Study EPILYMPH.
    Fortuny J; de Sanjosé S; Becker N; Maynadié M; Cocco PL; Staines A; Foretova L; Vornanen M; Brennan P; Nieters A; Alvaro T; Boffetta P
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):921-5. PubMed ID: 16702371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.
    Jick SS; Choi H; Li L; McInnes IB; Sattar N
    Ann Rheum Dis; 2009 Apr; 68(4):546-51. PubMed ID: 18662929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between statin therapy and tendon rupture: a case-control study.
    Beri A; Dwamena FC; Dwamena BA
    J Cardiovasc Pharmacol; 2009 May; 53(5):401-4. PubMed ID: 19454900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.